Vimarsana
Biggest News Aggregation in the World

Page 5 - Sciences Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sciences Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sciences Ltd Today - Breaking & Trending Today

Reviewing Relief Therapeutics (OTCMKTS:RLFTF) & Roivant Sciences (NASDAQ:ROIV) - Vimarsana News

Reviewing Relief Therapeutics (OTCMKTS:RLFTF) & Roivant Sciences (NASDAQ:ROIV)

Relief Therapeutics (OTCMKTS:RLFTF – Get Free Report) and Roivant Sciences (NASDAQ:ROIV – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations and dividends. Analyst Ratings This is a breakdown of recent […]

Max Healthcare, Aster DM, KIMS shares tank up to 8% today. Here's why - Vimarsana News

Max Healthcare, Aster DM, KIMS shares tank up to 8% today. Here's why

Max Healthcare Institute Ltd tanked 7.68 per cent to Rs 734. Shares of KIMS fell 3.23 per cent to Rs 2,182. Narayana Hrudayalaya shares declined 1.66 per cent to Rs 1,311.70.

Roivant Sciences Ltd. (NASDAQ:ROIV) Stock Holdings Lifted by Deerfield Management Company L.P. Series C - Vimarsana News

Roivant Sciences Ltd. (NASDAQ:ROIV) Stock Holdings Lifted by Deerfield Management Company L.P. Series C

Deerfield Management Company L.P. Series C raised its position in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 18.4% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,604,487 shares of the company’s stock after acquiring an additional 249,513 shares during […]

Source: wkrb13.com
Wolfe Research Begins Coverage on Roivant Sciences (NASDAQ:ROIV) - Vimarsana News

Wolfe Research Begins Coverage on Roivant Sciences (NASDAQ:ROIV)

Wolfe Research started coverage on shares of Roivant Sciences (NASDAQ:ROIV – Free Report) in a research note published on Thursday, Marketbeat reports. The brokerage issued an outperform rating and a $17.00 price target on the stock. A number of other equities analysts have also recently commented on ROIV. Deutsche Bank Aktiengesellschaft started coverage on shares […]

Silverarc Capital Management LLC Invests $1.17 Million in Roivant Sciences Ltd. (NASDAQ:ROIV) - Vimarsana News

Silverarc Capital Management LLC Invests $1.17 Million in Roivant Sciences Ltd. (NASDAQ:ROIV)

Silverarc Capital Management LLC purchased a new position in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 100,000 shares of the company’s stock, valued at approximately $1,168,000. A number of other institutional investors have also recently […]

Source: wkrb13.com